Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer

Int J Infect Dis. 2022 Sep:122:1005. doi: 10.1016/j.ijid.2022.06.036. Epub 2022 Jun 26.

Authors

Yuya Kamura¹, Kosei Matsue²

Affiliations

¹ Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan.
² Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan. Electronic address: koseimatsue@gmail.com.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Rhabdomyolysis*
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines